Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Zon

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Nucleic Acids Research|September 25, 1986
Alkyl phosphotriester modified oligodeoxyribonucleotides. V. Synthesis and absolute configuration of Rp and Sp diastereomers of an ethyl phosphotriester (Et) modified EcoRI recognition sequence, d[GGAA(Et)TTCC]. A synthetic approach to regio- and stereospecific ethylation-interference studiesK A Gallo, K L Shao, L R Phillips, et al.
Nucleic Acids Research|November 25, 1986
Phosphorothioate-modified oligodeoxyribonucleotides. III. NMR and UV spectroscopic studies of the Rp-Rp, Sp-Sp, and Rp-Sp duplexes, [d(GGSAATTCC)]2, derived from diastereomeric O-ethyl phosphorothioatesL A LaPlanche, T L James, C Powell, et al.
The Journal of Experimental Medicine|December 1, 1993
p120 GAP requirement in normal and malignant human hematopoiesisT Skorski, P Kanakaraj, M Nieborowska-Skorska, et al.
Blood|July 15, 1995
Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cellsT Skorski, P Kanakaraj, M Nieborowska-Skorska, et al.
The Journal of Infectious Diseases|November 1, 1993
Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophagesC F Perno, A Bergamini, C D Pesce, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cellsM Matsukura, G Zon, K Shinozuka, et al.
Nucleic Acids Research|September 25, 1990
Crystal and solution structures of the oligonucleotide d(ATGCGCAT)2: a combined X-ray and NMR studyG R Clark, D G Brown, M R Sanderson, et al.
Antisense Research and Development|January 1, 1993
Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trialE Bayever, P L Iversen, M R Bishop, et al.
Antisense & Nucleic Acid Drug Development|May 4, 2001
Safety of intracoronary administration of c-myc antisense oligomers after percutaneous transluminal coronary angioplasty (PTCA)F Roqué, G Mon, J Belardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignanciesM R Bishop, P L Iversen, E Bayever, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Nucleic Acids Research|September 25, 1986
Alkyl phosphotriester modified oligodeoxyribonucleotides. V. Synthesis and absolute configuration of Rp and Sp diastereomers of an ethyl phosphotriester (Et) modified EcoRI recognition sequence, d[GGAA(Et)TTCC]. A synthetic approach to regio- and stereospecific ethylation-interference studiesK A Gallo, K L Shao, L R Phillips, et al.
Nucleic Acids Research|November 25, 1986
Phosphorothioate-modified oligodeoxyribonucleotides. III. NMR and UV spectroscopic studies of the Rp-Rp, Sp-Sp, and Rp-Sp duplexes, [d(GGSAATTCC)]2, derived from diastereomeric O-ethyl phosphorothioatesL A LaPlanche, T L James, C Powell, et al.
The Journal of Experimental Medicine|December 1, 1993
p120 GAP requirement in normal and malignant human hematopoiesisT Skorski, P Kanakaraj, M Nieborowska-Skorska, et al.
Blood|July 15, 1995
Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cellsT Skorski, P Kanakaraj, M Nieborowska-Skorska, et al.
The Journal of Infectious Diseases|November 1, 1993
Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophagesC F Perno, A Bergamini, C D Pesce, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cellsM Matsukura, G Zon, K Shinozuka, et al.
Nucleic Acids Research|September 25, 1990
Crystal and solution structures of the oligonucleotide d(ATGCGCAT)2: a combined X-ray and NMR studyG R Clark, D G Brown, M R Sanderson, et al.
Antisense Research and Development|January 1, 1993
Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trialE Bayever, P L Iversen, M R Bishop, et al.
Antisense & Nucleic Acid Drug Development|May 4, 2001
Safety of intracoronary administration of c-myc antisense oligomers after percutaneous transluminal coronary angioplasty (PTCA)F Roqué, G Mon, J Belardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignanciesM R Bishop, P L Iversen, E Bayever, et al.
Pageof 15